Insider Stock Trading History of Primiano Christopher Brett


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Primiano Christopher Brett since year 2005. The trader's CIK number is 1603510. At the time of this reporting, Primiano Christopher Brett is the SVP, OPS, BUS DEV, GC & SEC of Karyopharm Therapeutics Inc. . (stock ticker symbol KPTI). See this page for all insider trading activities at Karyopharm Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Primiano Christopher Brett since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 KPTI Karyopharm Therapeutics Inc. Sale 1,500 12.00 18,000
2017-09-15 KPTI Karyopharm Therapeutics Inc. Sale 2,000 11.00 22,000
2017-06-26 KPTI Karyopharm Therapeutics Inc. Sale 805 10.03 8,070
2017-08-29 KPTI Karyopharm Therapeutics Inc. Sale 2,195 10.00 21,950
2016-11-09 KPTI Karyopharm Therapeutics Inc. Sale 4,342 8.19 35,543
2016-11-05 KPTI Karyopharm Therapeutics Inc. Option Ex 15,000 .00 0
2014-05-13 KPTI Karyopharm Therapeutics Inc. Buy 1,000 26.75 26,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Primiano Christopher Brett (SVP, OPS, BUS DEV, GC & SEC of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.